Elevance Health, Inc.
ELV
Ci-dessous : le cours en direct de Elevance Health, Inc. (ELV), un graphique 1 an, 8 indicateurs (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume) et le mode de comparaison. Ajoutez à votre portefeuille, mettez en favori ou définissez des alertes de prix.
Elevance Health, Inc. (ELV) est une entreprise du secteur Healthcare basée en United States. Active dans Healthcare Plans, elle emploie environ 96,129 personnes. Sur l'année écoulée, ELV a évolué entre 273.71 et 436.24 USD. Le PER (TTM) avoisine 16.5 pour une capitalisation d'environ 80.92B USD. Le rendement en dividendes actuel est de 1.84%.
- Prev close
- $372.85
- Volume (24h)
- $716.45M
- Market cap
- $80.92B
- Currency
- USD
Score
52/ 100 · Mitigé
- Valeur72
- Qualité35
- Momentum57
- Croissance24
- Risque78
- Dividende57
- Liquidité44
Composé à partir de données de marché publiques. Informatif uniquement — pas un conseil en investissement.
Projection de tendance
Là où la tendance récente pointe si elle se poursuit.
- +5 barres
- 375.9831 +0.77%
- +20 barres
- 379.9838 +1.84%
- +60 barres
- 381.5429 +2.26%
- +120 barres
- 381.6002 +2.28%
Continuation par régression linéaire — pas une prédiction, pas un conseil en investissement. ±1σ ≈ 68% · ±2σ ≈ 95%: ±0.0405 USD.
Interprétation
Les signaux composites paraissent mitigés. Force : profil de risque avec faiblesse : croissance. Le prix est au milieu de la plage récente, la tendance est ascendante.
Observation descriptive — ce n'est pas un conseil en investissement.
Décomposition du score
Les valeurs brutes derrière chaque pilier pour voir ce que le score composite mesure.
- Valeur72/100
Valeur semble robuste — porté par PER (16.5).
PER:16.5P/B:1.81PEG:1.32 - Qualité35/100
Qualité semble faible — porté par Marge brute (25.99%).
ROE:11.13%ROA:3.83%Marge nette:2.47%Marge brute:25.99% - Momentum57/100
Momentum semble mitigé — porté par Variation 52 sem (34.96%).
Variation 52 sem:34.96% - Croissance24/100
Croissance semble fragile — porté par Croissance BPA (-13.10%).
Croissance CA:1.40%Croissance BPA:-13.10% - Risque78/100
Risque semble solide — porté par Dette / capitaux (68.95).
Bêta:0.68Dette / capitaux:68.95Intérêts à découvert:3.10% - Dividende57/100
Dividende semble mitigé — porté par Taux de distribution (30.34%).
Rendement dividende:1.84%Taux de distribution:30.34% - Liquidité44/100
Liquidité semble faible — porté par Ratio courant (1.52).
Ratio courant:1.52Ratio rapide:1.37
Calculé à partir de données de marché publiques — informatif, pas un conseil en investissement.
Niveaux de référence
Retracements et extensions de Fibonacci sur la plage récente.
Référence uniquement — ce n'est pas un conseil en investissement.
Ces coordonnées décrivent les regroupements de prix passés, pas où acheter ou vendre. Faites vos propres recherches avant toute transaction.
- RésistanceExtension Fib +161.8%615.5467 USD+64.98% du prix actuel
- RésistanceExtension Fib +100%547.06 USD+46.62% du prix actuel
- RésistanceExtension Fib +61.8%504.7267 USD+35.28% du prix actuel
- RésistanceExtension Fib +27.2%466.383 USD+25.00% du prix actuel
- RésistanceRetracement Fib 23.6%410.0865 USD+9.91% du prix actuel
- RésistanceRetracement Fib 38.2%393.9068 USD+5.57% du prix actuel
- RésistancePoint médian Fib 50%380.83 USD+2.07% du prix actuel
- Actuel373.11 USD
- SupportRetracement Fib 61.8%367.7532 USD-1.44% du prix actuel
- SupportRetracement Fib 78.6%349.1355 USD-6.43% du prix actuel
- SupportExtension Fib −27.2%295.277 USD-20.86% du prix actuel
- SupportExtension Fib −61.8%256.9333 USD-31.14% du prix actuel
- SupportExtension Fib −100%214.6 USD-42.48% du prix actuel
Financials
- 52w high
- $436.24
- 52w low
- $273.71
- 52w change
- 34.96%
- Day high
- $377.76
- Day low
- $365.38
- P/E (TTM)
- 16.5
- Forward P/E
- 12.58
- PEG
- 1.32
- Price / Book
- 1.81
- Beta (5Y)
- 0.68
- Enterprise value
- 74.59B
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- EPS (TTM)
- $22.61
- Forward EPS
- $29.65
- Dividend yield
- 1.84%
- Dividend rate
- $6.88
- Payout ratio
- 30.34%
- Revenue (TTM)
- 201.11B
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Debt / Equity
- 68.95
- Current ratio
- 1.52
- Quick ratio
- 1.37
- Profit margin
- 2.47%
- Gross margin
- 25.99%
- Return on assets
- 3.83%
- Return on equity
- 11.13%
- Shares outstanding
- 216.87M
- Float
- 216.41M
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Analyst & Risk
- Beta (vs S&P 500)
- 0.68
- less volatile
- 52-week change
- 34.96%
- Short % of float
- 3.10%
- Short ratio (days)
- 3.32
- Debt / Equity
- 68.95
- very high leverage
- Current ratio
- 1.52
- Quick ratio
- 1.37
- ROE
- 11.13%
- ROA
- 3.83%
- PEG ratio
- 1.32
- fair
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- Revenue growth
- 1.40%
- Earnings growth
- -13.10%
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Insider holdings
- 0.18%
- Institutional
- 93.54%
Recent rating changes
- 2026-07-17Leerink PartnersMarket Perform → Market Performmain
- 2026-07-16RBC CapitalSector Perform → Sector Performmain
- 2026-07-16Wells FargoOverweight → Overweightmain
- 2026-07-16GuggenheimBuy → Buymain
- 2026-07-16BarclaysOverweight → Overweightmain
- 2026-07-16BairdNeutral → Neutralmain
- 2026-07-14TD CowenBuy → Buymain
- 2026-07-14Truist SecuritiesBuy → Buymain
Financial documents
- Periodic Financial Reports10-Q2026-07-15
- Annual report of employee stock purchase11-K2026-06-17
- Corporate Changes & Voting Matters8-K2026-06-10
- Corporate Changes & Voting Matters8-K2026-05-13
- Corporate Changes & Voting Matters8-K2026-04-22
- Proxy StatementsDEFA14A2026-03-27
- Corporate Changes & Voting Matters8-K2026-03-10
- Corporate Changes & Voting Matters8-K2026-03-02
- Corporate Changes & Voting Matters8-K2026-02-26
- Periodic Financial Reports10-K2026-02-06
- Corporate Changes & Voting Matters8-K2026-01-28
- Corporate Changes & Voting Matters8-K2025-12-10
Actualités récentes
- Equal-Weight Strategy RSP Could Outrun SPY if This Macro Shift Continues24/7 Wall St.1d ago
- Podiatrist-approved sneakers and shoes help you put your best foot forward — from $25TheStreet1d ago
- Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?Motley Fool2d ago
- Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform RatingMT Newswires2d ago
- Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform RatingMT Newswires2d ago
- What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?Trefis2d ago
- Elevance Health CEO Snaps Up Stock After Post-Earnings SlideBarrons.com2d ago
- Elevance Health Insider Bought Shares Worth $1,002,230, According to a Recent SEC FilingMT Newswires2d ago
Associés
Autres actifs de cette catégorie.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Discussion en direct
Connexion to join the discussion.
- Aucun commentaire. Soyez le premier.